Somaxon Settles IP Rows With Mylan, Par Over Insomnia Drug
Somaxon Pharmaceutical Inc. said Tuesday it had settled patent infringement suits against generic drugmakers Mylan Inc. and Par Pharmaceutical Cos. Inc., striking deals that will keep generic versions of Somaxon's insomnia...To view the full article, register now.
Already a subscriber? Click here to view full article